Results 191 to 200 of about 160,552 (312)

Transplantation tolerance, microchimerism, and the two-way paradigm [PDF]

, 1998
Demetris, AJ, Starzl, TE
core   +1 more source

Comparative Efficacy of Combined and Standalone Oral Immunotherapies for Peanut Allergy: a Bayesian Network Meta-Analysis of RCTs. [PDF]

Clin Rev Allergy Immunol
Tian X, Liu S, Li L, Guan K.
europepmc   +1 more source

Vaccinating patients on biologics for atopic disease: Clinical considerations and evidence-based recommendations. [PDF]

Allergy Asthma Proc
Chase NM.
europepmc   +1 more source

Autosomal-dominant hyper-IgE syndrome is associated with appearance of infections early in life and/or neonatal rash: Evidence from the Italian cohort of 61 patients with elevated IgE [PDF]

, 2019
Badolato R, Cancrini C, Carrabba M, Cortesi M, Cossu F, Dellepiane RM, Dotta L, Giacomelli M, Giardino G, IPINET (Italian Network for Primary Immunodeficiencies), Lorenzini T, Pietrogrande MC, Pignata C, Plebani A, Rivellini V, Scomodon O, Soresina A, Specchia F   +17 more
core   +1 more source

Editorial: Rhinitis and pollution. [PDF]

Front Allergy
Chong-Neto HJ, Gómez RM.
europepmc   +1 more source

The Microbiology and Immunology of Normal Physiologic Birth: A Plea for the Nature of Mother [PDF]

, 2013
Hanson, Lisa, VandeVusse, Leona
core   +1 more source

Genetic Contribution to Asthma Informs Acute Chest Syndrome Pathophysiology and Risk Stratification

American Journal of Hematology, EarlyView.
ABSTRACT Acute chest syndrome (ACS) is a severe complication of sickle cell disease (SCD) occurring in ~50% of patients, some presenting frequent episodes. We lack tools to identify patients at high risk of ACS occurrence or frequent episodes. Epidemiological studies have found an association between asthma and ACS, but whether this link is causal is ...
Sara El Aouhel, Vanessa Bellegarde, Stennio Da Silva Faria, Tristan St‐Laurent, Estelle Lecluze, Anne‐Laure Pham Hung d’Alexandry d’Orengiani, Frédéric Galactéros, Pablo Bartolucci, Marc‐André Legault, Guillaume Lettre, Thomas Pincez   +10 more
wiley   +1 more source

Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia

American Journal of Hematology, EarlyView.
ABSTRACT Preclinical studies showed a synergistic antileukemia activity with combination of selective XPO1 inhibitor selinexor (SEL) and venetoclax (VEN), with potential to overcome VEN resistance by reducing the anti‐apoptotic protein MCL1. In an investigator‐sponsored, open‐label, phase Ib study (NCT03955783), adult patients with relapsed or ...
Somedeb Ball, Farrukh T. Awan, Ben K. Tomlinson, Tess Stopczynski, Melissa A. Fischer, Zhiguo Zhao, Kateryna Fedorov, Ashwin Kishtagari, Sanjay R. Mohan, Gregory D. Ayers, Michael T. Byrne, Michael R. Savona   +11 more
wiley   +1 more source

Real‐World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry

American Journal of Hematology, EarlyView.
ABSTRACT Ravulizumab, a second‐generation complement component 5 inhibitor (C5i) derived from eculizumab, with improved pharmacokinetics, is the current standard‐of‐care treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH), where available.
Alexander Röth, Christopher J. Patriquin, Jeff Szer, Louis Terriou, Ami S. Patel, Jesse Metzger, Philippe Gustovic, Jun‐ichi Nishimura, Robert A. Brodsky   +8 more
wiley   +1 more source

Atopic Comorbidities Associated With Chronic Spontaneous Urticaria: A Case-Control Analysis of the All of Us Research Program. [PDF]

JEADV Clin Pract
Cortes JA, Adjei-Frimpong NA, Fakhouri SK, Delacqua F, Oldenburg R.   +4 more
europepmc   +1 more source